253 related articles for article (PubMed ID: 18787205)
21. OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness.
Papamichos SI; Kotoula V; Tarlatzis BC; Agorastos T; Papazisis K; Lambropoulos AF
Mol Hum Reprod; 2009 May; 15(5):269-70. PubMed ID: 19258399
[TBL] [Abstract][Full Text] [Related]
22. Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response.
Wang X; Zhao Y; Xiao Z; Chen B; Wei Z; Wang B; Zhang J; Han J; Gao Y; Li L; Zhao H; Zhao W; Lin H; Dai J
Stem Cells; 2009 Jun; 27(6):1265-75. PubMed ID: 19489092
[TBL] [Abstract][Full Text] [Related]
23. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.
Asadi MH; Khalifeh K; Mowla SJ
J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657
[TBL] [Abstract][Full Text] [Related]
24. Functionally defined substates within the human embryonic stem cell compartment.
Tonge PD; Shigeta M; Schroeder T; Andrews PW
Stem Cell Res; 2011 Sep; 7(2):145-53. PubMed ID: 21763622
[TBL] [Abstract][Full Text] [Related]
25. Differential responses to retinoic acid and endocrine disruptor compounds of subpopulations within human embryonic stem cell lines.
Annab LA; Bortner CD; Sifre MI; Collins JM; Shah RR; Dixon D; Karimi Kinyamu H; Archer TK
Differentiation; 2012 Nov; 84(4):330-43. PubMed ID: 22906706
[TBL] [Abstract][Full Text] [Related]
26. OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.
Choi SH; Kim JK; Jeon HY; Eun K; Kim H
Mol Cells; 2019 Feb; 42(2):135-142. PubMed ID: 30622231
[TBL] [Abstract][Full Text] [Related]
27. OCT4 expression in human uterine myometrial stem/progenitor cells.
Ono M; Kajitani T; Uchida H; Arase T; Oda H; Nishikawa-Uchida S; Masuda H; Nagashima T; Yoshimura Y; Maruyama T
Hum Reprod; 2010 Aug; 25(8):2059-67. PubMed ID: 20576635
[TBL] [Abstract][Full Text] [Related]
28. Nocodazole treatment decreases expression of pluripotency markers Nanog and Oct4 in human embryonic stem cells.
Kallas A; Pook M; Maimets M; Zimmermann K; Maimets T
PLoS One; 2011 Apr; 6(4):e19114. PubMed ID: 21559451
[TBL] [Abstract][Full Text] [Related]
29. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
[TBL] [Abstract][Full Text] [Related]
30. Ethyl-p-methoxycinnamate enhances oct4 expression and reinforces pluripotency through the NF-κB signaling pathway.
Ai H; Qin H; Li J; Niu C; Song Z; Bao Y; Sun L; Zheng L; Li Y
Biochem Pharmacol; 2020 Jul; 177():113984. PubMed ID: 32311348
[TBL] [Abstract][Full Text] [Related]
31. Analysis of co-expression of OCT4, NANOG and SOX2 in pluripotent cells of the porcine embryo, in vivo and in vitro.
du Puy L; Lopes SM; Haagsman HP; Roelen BA
Theriogenology; 2011 Feb; 75(3):513-26. PubMed ID: 21074831
[TBL] [Abstract][Full Text] [Related]
32. A Novel Variant of
Poursani EM; Mehravar M; Mohammad Soltani B; Mowla SJ; Trosko JE
Avicenna J Med Biotechnol; 2017; 9(3):142-145. PubMed ID: 28706610
[TBL] [Abstract][Full Text] [Related]
33. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
Gu P; Le Menuet D; Chung AC; Cooney AJ
Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
[TBL] [Abstract][Full Text] [Related]
34. DNA methylation of the Oct4A enhancers in embryonal carcinoma cells after etoposide treatment is associated with alternative splicing and altered pluripotency in reversibly senescent cells.
Baryshev M; Inashkina I; Salmina K; Huna A; Jackson TR; Erenpreisa J
Cell Cycle; 2018; 17(3):362-366. PubMed ID: 29372665
[TBL] [Abstract][Full Text] [Related]
35. C-MYC controlled TIP110 protein expression regulates OCT4 mRNA splicing in human embryonic stem cells.
Liu Y; Timani K; Ou X; Broxmeyer HE; He JJ
Stem Cells Dev; 2013 Mar; 22(5):689-94. PubMed ID: 23088399
[TBL] [Abstract][Full Text] [Related]
36. [Identification of the OCT4-pg1 retrogene and NANOG gene expression in the human embryonic eye].
Firsova NV; Markintantova IuV; Smirnova IuA; Panova IG; Sukhikh GT; Zinov'eva RD; Mitashov VI
Izv Akad Nauk Ser Biol; 2008; (2):134-8. PubMed ID: 18946985
[TBL] [Abstract][Full Text] [Related]
37. Oct4 expression in in-vitro-produced sheep blastocysts and embryonic-stem-like cells.
Sanna D; Sanna A; Mara L; Pilichi S; Mastinu A; Chessa F; Pani L; Dattena M
Cell Biol Int; 2009 Dec; 34(1):53-60. PubMed ID: 19947952
[TBL] [Abstract][Full Text] [Related]
38. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
Liu L; Wu L; Wei X; Ling J
Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
[TBL] [Abstract][Full Text] [Related]
39. HIF-2α and Oct4 have synergistic effects on survival and myocardial repair of very small embryonic-like mesenchymal stem cells in infarcted hearts.
Zhang S; Zhao L; Wang J; Chen N; Yan J; Pan X
Cell Death Dis; 2017 Jan; 8(1):e2548. PubMed ID: 28079892
[TBL] [Abstract][Full Text] [Related]
40. Specific knockdown of Oct4 and beta2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells.
Matin MM; Walsh JR; Gokhale PJ; Draper JS; Bahrami AR; Morton I; Moore HD; Andrews PW
Stem Cells; 2004; 22(5):659-68. PubMed ID: 15342930
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
